Pharma Exabyte 2015

Utilization of Big Data in different R&D stages (clinical research, drug discovery, genomics, translational medicine)
Large scale and holistic compound scale activity prediction Pooled data from multiple clinical trials in SDTM format
Implication of Big Data in the early phase of drug development
Leveraging large amounts of data to advance patient-centric treatment
Pooling data from multiple sources to tailor treatments
Understanding the real value of big data
Case studies from various therapeutic areas
Data security

Speakers
John Wise, Chris Day, Athula Herath, Hugo Ceulemans, Pantaleo nacci, Andreas Bender, Rong Chen, Martin Ryzl, Manuel Martin and many more...